Status:

TERMINATED

PlayGait: A Dynamic Exoskeleton

Lead Sponsor:

Orthocare Innovations, LLC

Collaborating Sponsors:

National Institute on Disability, Independent Living, and Rehabilitation Research

Conditions:

Cerebral Palsy

Eligibility:

All Genders

3-4 years

Phase:

NA

Brief Summary

PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of ...

Eligibility Criteria

Inclusion

  • Age 3 - 4 years (at time of informed consent)
  • Hemiplegic cerebral palsy
  • If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home)
  • Ability to walk at least 10 meters without the use of assistive devices or AFOs
  • Ability to walk at least 1 minute without the use of assistive devices or AFOs
  • Stiff knee gait - less than normal knee flexion during swing phase
  • Hip flexion passive range of motion contracture less than 20 degrees
  • Gross Motor Function Classification System (GMFCS) Levels I-II
  • Modified Ashworth Scale (MAS) \<=2 for the gastrocnemius soleus, rectus femoris, and hamstrings
  • Family has resources to attend all study sessions (transportation, schedule)
  • Ability to speak and understand in English

Exclusion

  • Orthopedic surgery in the last year
  • Foster children or wards of the state
  • Use wheelchair or stroller mobility as their primary method of independent mobility
  • Severe visual impairment such that the visual impairment itself functionally limits mobility
  • Phenol or Botox injections to the legs in the last 3 months
  • Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable)
  • Lower limb fracture in the last 3 months
  • Planned surgery or changes to movement disorder medication during the study period
  • Inability to understand directions sufficiently to complete the study assessments
  • Cognitive, behavioral, or any other issues that may not allow for effective study participation
  • Unwilling to complete the study protocol

Key Trial Info

Start Date :

March 11 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 3 2023

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT05318690

Start Date

March 11 2022

End Date

January 3 2023

Last Update

October 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Orthocare Innovations, LLC

Edmonds, Washington, United States, 98020